Img.Lg

IMG.LG maintains a strong liquidity position with a current ratio of 1.95, indicating the company can cover its short-term liabilities with its short-term assets. The company's cash and equivalents amount to NGN 2.24 billion, which is a significant portion of its total assets of NGN 14.8 billion. The debt-to-equity ratio is 0.01, suggesting that the company is largely equity-funded and has minimal long-term debt obligations.

In terms of profitability, IMG.LG reports a return on equity (ROE) of 8.36% and a return on assets (ROA) of 6.69%. These figures indicate that the company is generating a moderate return on its equity and assets, which is in line with the typical performance of firms in the commodity chemicals industry. The operating income of NGN 1.47 billion and net income of NGN 989.85 million reflect a healthy margin, although the gross profit margin of 48.7% suggests that the company is facing competitive pressures in its cost structure.

The company's revenue is primarily concentrated in the production and sale of commodity chemicals, with no significant diversification into other product lines or geographic regions. This concentration may expose the company to market-specific risks, such as fluctuations in raw material prices and demand volatility. The lack of detailed segment data limits the ability to assess the performance of individual product lines or geographic regions.

Looking at the growth trajectory, IMG.LG has demonstrated a consistent revenue performance, with a revenue of NGN 8.38 billion in the latest reporting period. The company's capital expenditure of NGN 3.24 billion indicates a significant investment in its operations, which may support future growth. However, the free cash flow of NGN -2.27 billion suggests that the company is reinvesting heavily in its operations rather than distributing cash to shareholders.

The risk assessment for IMG.LG indicates a low level of liquidity and dilution risk. The company has no immediate filing-based liquidity or dilution flags, and its capital structure is stable with minimal long-term debt. The dilution potential is also low, as the number of shares outstanding remains unchanged between basic and diluted shares. The company's financial health is further supported by its strong cash reserves and low debt levels.

Recent events and filings do not indicate any significant changes in the company's operations or financial strategy. The company continues to focus on maintaining its market position in the commodity chemicals industry and managing its capital expenditures effectively. There are no notable regulatory or geopolitical risks currently affecting the company's operations.